from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3847/-

LFCtreatmentdescriptionclass of inhibitor

1.755

Amikacinug/mL Amikacintranslation

1.039

Cap5-10ug/mL Capreomycintranslation

1.123

Rox10-50 ug/mL Roxithromycintranslation

0.559

SM2-5 ug/mL Streptomycintranslation

2.716

Tet5-10 ug/mL Tetracyclinetranslation

1.387

Rif0.2-5ug/mL Rifampicintranscription

-0.002

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.085

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.999

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.160

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.952

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.689

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.433

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.259

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.166

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.830

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.241

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.243

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.941

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.516

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.563

KCN5-20 ug/mL Potassium cyaniderespiration

-0.847

NaN30.2-2 mM Sodium aziderespiration

1.563

Nigericin50 uM Nigericinrespiration

0.296

TRC10-150 ug/mL Triclosanrespiration

0.623

TRZ10-25 ug/mL Thioridazinerespiration

-1.366

Valinomycin0.5-10 uM Valinomycinrespiration

-0.485

ZnSO42 mM ZnSO4respiration

-0.381

menadione6-10 ug/mL Menadionerespiration

-1.092

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.310

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.251

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.031

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.097

NRP_1Non-replicating persistence stage 1dosRassociated

0.456

Amp0.2mg/mL AmpicillincellWall

-0.260

Cephalexin20-100 ug/mL CephalexincellWall

-0.371

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.113

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.859

EMB10-20 ug/mL EthambutolcellWall

0.424

Eta12-40 ug/mL EthionamidecellWall

0.729

INH0.2-0.4 ug/mL IsoniazidcellWall

0.006

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.648

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.404

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.162

BZA0.12 mg/mL BenzamidearomaticAmides

-0.269

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.289

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.259

H2O24 mM hydrogen peroxideDNAdamaging

-0.034

Levo10 ug/mL LevofloxacinDNAdamaging

0.209

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.365

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.502

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.358

UVUV-irradiationDNAdamaging

-1.063

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.668

Antimycin12.5-50 ug/mL Antimycin A?

-0.450

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.053

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.665

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.191

PA8240.2-2 ug/mL PA-824?

-0.640

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.116

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.803

Verapamil50 uM Verapamil?

-0.406

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.714

methoxatin10-20 ug/mL Methoxatin?